Lung Cancer
Volume 70, Issue 1 , Pages 37-42, October 2010

Chemoprevention of murine lung cancer by gefitinib in combination with prostacyclin synthase overexpression☆

  • Robert L. Keith

      Affiliations

    • Veterans Administration Medical Center, Division of Pulmonary Sciences and Critical Care Medicine, Denver, CO 80220, United States
    • University of Colorado Denver, Department of Medicine, Denver, CO 80262, United States
    • ,
  • Vijaya Karoor

      Affiliations

    • University of Colorado Denver, Department of Medicine, Denver, CO 80262, United States
    • ,
  • Anthony B. Mozer

      Affiliations

    • Veterans Administration Medical Center, Division of Pulmonary Sciences and Critical Care Medicine, Denver, CO 80220, United States
    • ,
  • Tyler M. Hudish

      Affiliations

    • Veterans Administration Medical Center, Division of Pulmonary Sciences and Critical Care Medicine, Denver, CO 80220, United States
    • ,
  • Mysan Le

      Affiliations

    • Veterans Administration Medical Center, Division of Pulmonary Sciences and Critical Care Medicine, Denver, CO 80220, United States
    • ,
  • York E. Miller

      Affiliations

    • Veterans Administration Medical Center, Division of Pulmonary Sciences and Critical Care Medicine, Denver, CO 80220, United States
    • University of Colorado Denver, Department of Medicine, Denver, CO 80262, United States
    • Corresponding Author InformationCorresponding author at: Department of Medicine, Denver VA Medical Center, 1055 Clermont St., Pulmonary 111A, Denver, CO 80220, United States. Tel.: +1 303 393 2869; fax: +1 303 393 4639.

Received 11 September 2009; received in revised form 9 December 2009; accepted 6 January 2010. published online 29 January 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Supported by Department of Veterans Affairs Merit Review Grants (YEM and RLK) and NCI P50 CA58187 (SPORE in Lung Cancer, YEM and RLK).

PII: S0169-5002(10)00006-1

doi:10.1016/j.lungcan.2010.01.004

Lung Cancer
Volume 70, Issue 1 , Pages 37-42, October 2010

Article Tools

* Image Usage & Resolution